MedPath

Multicentre randomised cotrolled trial comparing bipolar with monopolar transurethral resection of the prostate

Phase 3
Conditions
Benign prostatic hyperplasia
Registration Number
JPRN-UMIN000010801
Lead Sponsor
osaka medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria were patients with documented or suspected prostate cancer, bladder calculus, neurogenic bladder, previous prostate surgery, renal impairment, associated hydronephrosis, and urethral stricture.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary end point in this study was safety, with a focus on perioperative findings such as operation time, decline of sodium level, clot retention, transfusion, and any other symptom relating to the procedures.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints were efficacy findings for patients after 36 months of follow-ups including development of urethral stricture.
© Copyright 2025. All Rights Reserved by MedPath